Acrodermatitis chronica atrophicans: Difference between revisions
Kiran Singh (talk | contribs) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 2: | Line 2: | ||
'''For patient information, click [[Acrodermatitis chronica atrophicans (patient information)|here]]''' | '''For patient information, click [[Acrodermatitis chronica atrophicans (patient information)|here]]''' | ||
{{ACA}} | {{ACA}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{Anahita}} {{RT}} | ||
{{SK}} Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA | {{SK}} Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA | ||
| Line 38: | Line 38: | ||
[[Category:Zoonoses]] | [[Category:Zoonoses]] | ||
[[Category:Spirochaetes]] | [[Category:Spirochaetes]] | ||
Latest revision as of 07:54, 4 August 2022
For patient information, click here
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Raviteja Guddeti, M.B.B.S. [3]
Synonyms and keywords: Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Acrodermatitis chronica atrophicans from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies